Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis.
Consuegra-Fernández M, Julià M, Martínez-Florensa M, Aranda F, Català C, Armiger-Borràs N, Arias MT, Santiago F, Guilabert A, Esteve A, Muñoz C, Ferrándiz C, Carrascosa JM, Pedrosa E, Romaní J, Alsina M, Mascaró-Galy JM, Lozano F. Consuegra-Fernández M, et al. Among authors: alsina m. Cell Mol Immunol. 2018 Oct;15(10):898-906. doi: 10.1038/cmi.2017.119. Epub 2017 Dec 11. Cell Mol Immunol. 2018. PMID: 29225340 Free PMC article.
Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry.
Dávila-Seijo P, Dauden E, Descalzo MA, Carretero G, Carrascosa JM, Vanaclocha F, Gómez-García FJ, De la Cueva-Dobao P, Herrera-Ceballos E, Belinchón I, López-Estebaranz JL, Alsina M, Sánchez-Carazo JL, Ferrán M, Torrado R, Ferrandiz C, Rivera R, Llamas M, Jiménez-Puya R, García-Doval I; BIOBADADERM Study Group. Dávila-Seijo P, et al. Among authors: alsina m. J Invest Dermatol. 2017 Feb;137(2):313-321. doi: 10.1016/j.jid.2016.08.034. Epub 2016 Sep 25. J Invest Dermatol. 2017. PMID: 27677836 Free article.
Change over time in the rates of adverse events in patients receiving systemic therapy for psoriasis: A cohort study.
Descalzo MA, Carretero G, Ferrándiz C, Rivera R, Daudén E, Gómez-García FJ, de la Cueva P, Herrera-Ceballos E, Belinchón I, López-Estebaranz JL, Alsina M, Sánchez-Carazo JL, Ferrán M, Baniandrés O, Carrascosa JM, Llamas-Velasco M, Ruiz-Genao D, Herrera-Acosta E, Muñoz-Santos C, García-Doval I; Biobadaderm Study Group. Descalzo MA, et al. Among authors: alsina m. J Am Acad Dermatol. 2018 Apr;78(4):798-800. doi: 10.1016/j.jaad.2017.10.051. Epub 2017 Nov 13. J Am Acad Dermatol. 2018. PMID: 29146129 Free article. No abstract available.
Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in Spain.
Notario J, Deza G, Vilarrasa E, Valentí F, Muñoz C, Mollet J, Rocamora V, Carrascosa JM, Del Alcázar E, Alsina M, Vidal D, Puig L, López-Ferrer A, Riera J, Gallardo F, Ferran M. Notario J, et al. Among authors: alsina m. J Dermatolog Treat. 2019 Aug;30(5):424-429. doi: 10.1080/09546634.2018.1528000. Epub 2018 Dec 3. J Dermatolog Treat. 2019. PMID: 30244618
Effectiveness and safety of ustekinumab 90 mg in patients weighing 100 kg or less: a retrospective, observational, multicenter study.
Del Alcázar E, Ferran M, López-Ferrer A, Notario J, Vidal D, Riera J, Aparicio G, Gallardo F, Vilarrasa E, Alsina M, Puig L, Ferrándiz C, Carrascosa JM. Del Alcázar E, et al. Among authors: alsina m. J Dermatolog Treat. 2020 May;31(3):222-226. doi: 10.1080/09546634.2019.1597245. Epub 2019 Apr 2. J Dermatolog Treat. 2020. PMID: 30883242
The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry.
Munera-Campos M, Vilar-Alejo J, Rivera R, Carrascosa JM, Daudén E, Herrera-Acosta E, Sahuquillo-Torralba A, Gómez-García FJ, Baniandrés-Rodríguez O, de la Cueva P, López-Estebaranz JL, Belinchón I, Ferran M, Riera-Monroig J, Rodriguez L, Carretero G, García-Donoso C, Ballescá F, Llamas-Velasco M, Herrera-Ceballos E, Pujol-Marco C, Nieto-Benito LM, Ruiz-Genao DP, Alsina M, Descalzo MA, García-Doval I; BIOBADADERM Study Group. Munera-Campos M, et al. Among authors: alsina m. J Dermatolog Treat. 2022 Jun;33(4):2110-2117. doi: 10.1080/09546634.2021.1922572. Epub 2022 Mar 23. J Dermatolog Treat. 2022. PMID: 33913796
The risk of urinary tract infections in patients with psoriasis on systemic medications in Biobadaderm Registry: A prospective cohort study.
Sahuquillo-Torralba A, Carretero G, Rivera R, Ferrándiz C, Daudén-Tello E, de la Cueva P, Gómez-García FJ, Belinchón I, Herrera-Acosta E, Ruiz-Genao D, Ferrán M, Alsina M, Sánchez-Carazo JL, Baniandrés O, Fernández-Freire LR, Vilar J, García-Donoso C, Carrascosa JM, Llamas-Velasco M, Herrera-Ceballos E, López-Estebaranz JL, Pujol-Marco C, Descalzo MÁ, García-Doval I; Biobadaderm Study Group. Sahuquillo-Torralba A, et al. Among authors: alsina m. J Am Acad Dermatol. 2020 Mar;82(3):738-741. doi: 10.1016/j.jaad.2019.07.028. Epub 2019 Jul 13. J Am Acad Dermatol. 2020. PMID: 31306726 Free article. No abstract available.
Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry.
Daudén E, Carretero G, Rivera R, Ferrándiz C, Llamas-Velasco M, de la Cueva P, Belinchón I, Gómez-García FJ, Herrera-Acosta E, Ruiz-Genao DP, Ferrán-Farrés M, Alsina M, Baniandrés-Rodríguez O, Sánchez-Carazo JL, Sahuquillo-Torralba A, Fernández-Freire LR, Vilar-Alejo J, García-Donoso C, Carrascosa JM, Herrera-Ceballos E, López-Estebaranz JL, Botella-Estrada R, Segovia-Muñoz E, Descalzo MA, García-Doval I; BIOBADADERM Study Group. Daudén E, et al. Among authors: alsina m. J Am Acad Dermatol. 2020 Jul;83(1):139-150. doi: 10.1016/j.jaad.2020.03.033. Epub 2020 Mar 22. J Am Acad Dermatol. 2020. PMID: 32213306 Free article.
473 results